Terbutaline Sulfate (Akorn)
Welcome to the PulseAid listing for the Terbutaline Sulfate drug offered from Akorn. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Akorn |
NON-PROPRIETARY NAME: | Terbutaline Sulfate |
SUBSTANCE NAME: | TERBUTALINE SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | SUBCUTANEOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2010-02-01 |
END MARKETING DATE: | 0000-00-00 |
Terbutaline Sulfate HUMAN PRESCRIPTION DRUG Details:
Item Description | Terbutaline Sulfate from Akorn |
LABELER NAME: | Akorn |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1(mg/mL) |
START MARKETING DATE: | 2010-02-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17478-933_452dcbc2-05fd-4ede-bb1b-be661eb85b31 |
PRODUCT NDC: | 17478-933 |
APPLICATION NUMBER: | ANDA078151 |
Other TERBUTALINE SULFATE Pharmaceutical Manufacturers / Labelers: